Douglas A. Schuling

Chief Financial Officer, GENOPTIX INC.

Companies

Viridian Therapeutics, Inc.\DEBoard member Jun 17, 2014 to Jun 20, 2016¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARViridian Therapeutics, Inc.\DE, Board member